{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:39:16Z","timestamp":1778625556077,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Department of Molecular and Cellular Biology at the University of Guelph"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.neulet.2019.134404","type":"journal-article","created":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T11:08:58Z","timestamp":1564139338000},"page":"134404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Asenapine maleate normalizes low frequency oscillatory deficits in a neurodevelopmental model of schizophrenia"],"prefix":"10.1016","volume":"711","author":[{"given":"Tapia","family":"Foute Nelong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua D.","family":"Manduca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula M.","family":"Zonneveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5775-8950","authenticated-orcid":false,"given":"Melissa L.","family":"Perreault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2019.134404_bib0005","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1523\/JNEUROSCI.4623-06.2007","article-title":"Synchronization of neural activity across cortical areas correlates with conscious perception","volume":"27","author":"Melloni","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.134404_bib0010","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijpsycho.2006.07.007","article-title":"Working memory related gamma oscillations in schizophrenia patients","volume":"64","author":"Basar-Eroglu","year":"2007","journal-title":"Int. J. Psychophysiol."},{"key":"10.1016\/j.neulet.2019.134404_bib0015","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/schbul\/sbr056","article-title":"High vs low frequency neural oscillations in schizophrenia","volume":"37","author":"Moran","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neulet.2019.134404_bib0020","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1192\/bjp.bp.114.156075","article-title":"Frontal slow-wave activity as a predictor of negative symptoms, cognition and functional capacity in schizophrenia","volume":"208","author":"Chen","year":"2016","journal-title":"Br. J. Psychiatry."},{"key":"10.1016\/j.neulet.2019.134404_bib0025","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0006-3223(97)00428-9","article-title":"Low frontal electroencephalographic coherence in neuroleptic-free schizophrenic patients","volume":"44","author":"Tauscher","year":"1998","journal-title":"Biol. Psychiatry."},{"key":"10.1016\/j.neulet.2019.134404_bib0030","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.psychres.2016.11.030","article-title":"A typical antipsychotics normalize low-gamma evoked oscillations in patients with schizophrenia","volume":"247","author":"Alegre","year":"2017","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neulet.2019.134404_bib0035","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neuroimage.2010.02.009","article-title":"Antipsychotics reverse abnormal EEG complexity in drug-naive schizophrenia: a multiscale entropy analysis","volume":"15","author":"Takahashi","year":"2010","journal-title":"Neuroimage."},{"key":"10.1016\/j.neulet.2019.134404_bib0040","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1017\/S1461145711000848","article-title":"Acute administration of typical and atypical antipsychotics reduces EEG gamma power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in gamma power","volume":"15","author":"Jones","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neulet.2019.134404_bib0045","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1017\/S1461145712001034","article-title":"Antipsychotic compounds differentially modulate high-frequency oscillations in the rat nucleus accumbens: a comparison of first- and second-generation drugs","volume":"16","author":"Olszewski","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neulet.2019.134404_bib0050","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.51","article-title":"Reversal of evoked gamma oscillation deficits is predictive of antipsychotic activity with a unique profile for clozapine","volume":"6","author":"Hudson","year":"2016","journal-title":"Transl. Psychiatry."},{"key":"10.1016\/j.neulet.2019.134404_bib0055","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1056\/NEJMra035458","article-title":"Schizophrenia","volume":"349","author":"Freedman","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neulet.2019.134404_bib0060","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00213-003-1459-1","article-title":"Differential effects of iloperidone, clozapine, and haloperidol on working memory of rats in the delayed non-matching-to-position paradigm","volume":"169","author":"Gemperle","year":"2003","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.neulet.2019.134404_bib0065","doi-asserted-by":"crossref","first-page":"S466","DOI":"10.1016\/S0924-977X(07)70710-1","article-title":"Effects of asenapine on cognitive function in acute schizophrenia: a placebo- and risperidone-controlled trial","volume":"17","author":"Fleming","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neulet.2019.134404_bib0070","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bbr.2010.05.043","article-title":"Effects of asenapine, olanzapine, and risperidone on psychotomimetic-induced reversal-learning deficits in the rat","volume":"214","author":"McLean","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neulet.2019.134404_bib0075","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.neuropharm.2011.08.026","article-title":"Asenapine effects on cognitive and monoamine dysfunction elicited by subchronic phencyclidine administration","volume":"62","author":"Elsworth","year":"2012","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.neulet.2019.134404_bib0080","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00213-010-2091-5","article-title":"Asenapine improves phencyclidine-induced object recognition deficits in the rat: evidence for engagement of a dopamine D1receptor mechanism","volume":"214","author":"Snigdha","year":"2011","journal-title":"Psychopharmacology (Berl)."},{"issue":"3","key":"10.1016\/j.neulet.2019.134404_bib0085","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41386-018-0219-1","article-title":"State-dependent effects of the D 2 partial agonist aripiprazole on dopamine neuron activity in the MAM neurodevelopmental model of schizophrenia","volume":"44","author":"Sonnenschein","year":"2019","journal-title":"Neuropsychopharmacology."},{"issue":"8","key":"10.1016\/j.neulet.2019.134404_bib0090","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/j.neuropharm.2012.02.021","article-title":"Social isolation rearing in rats alters plasma tryptophan metabolism and is reversed by sub-chronic clozapine treatment","volume":"62","author":"M\u00f6ller","year":"2012","journal-title":"Neuropharmacology"},{"issue":"38","key":"10.1016\/j.neulet.2019.134404_bib0095","doi-asserted-by":"crossref","first-page":"8214","DOI":"10.1523\/JNEUROSCI.1274-04.2004","article-title":"Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors","volume":"24","author":"Centonze","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.134404_bib0100","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bbr.2014.07.042","article-title":"Asenapine sensitization from adolescence to adulthood and its potential molecular basis","volume":"273","author":"Shu","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neulet.2019.134404_bib0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00213-004-1793-y","article-title":"Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction","volume":"174","author":"Goldman-Rakic","year":"2004","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.neulet.2019.134404_bib0110","doi-asserted-by":"crossref","first-page":"16774","DOI":"10.1523\/JNEUROSCI.2772-14.2014","article-title":"D1-dependent 4 Hz oscillations and ramping activity in rodent medial frontal cortex during interval timing","volume":"34","author":"Parker","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.134404_bib0115","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cogbrainres.2004.06.012","article-title":"Cortico-striatal circuits and interval timing: coincidence detection of oscillatory processes","volume":"21","author":"Matell","year":"2004","journal-title":"Cogn. Brain Res."},{"key":"10.1016\/j.neulet.2019.134404_bib0120","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/mp.2017.50","article-title":"Delta-frequency stimulation of cerebellar projections can compensate for schizophrenia-related medial frontal dysfunction","volume":"22","author":"Parker","year":"2017","journal-title":"Mol. Psychiatry."},{"issue":"5","key":"10.1016\/j.neulet.2019.134404_bib0125","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1152\/jn.2002.87.5.2324","article-title":"Interaction of dopamine D1 and NMDA receptors mediates acute clozapine potentiation of glutamate EPSPs in rat prefrontal cortex","volume":"87","author":"Chen","year":"2002","journal-title":"J. Neurophysiol."},{"issue":"11","key":"10.1016\/j.neulet.2019.134404_bib0130","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/syn.20803","article-title":"Effects of asenapine on prefrontal N-methyl-D-aspartate receptor-mediated transmission: involvement of dopamine D1 receptors","volume":"64","author":"Jardemark","year":"2010","journal-title":"Synapse."},{"issue":"1","key":"10.1016\/j.neulet.2019.134404_bib0135","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbr.2007.06.012","article-title":"Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat","volume":"184","author":"Grayson","year":"2007","journal-title":"Behav. Brain Res."},{"issue":"37","key":"10.1016\/j.neulet.2019.134404_bib0140","doi-asserted-by":"crossref","first-page":"15085","DOI":"10.1073\/pnas.1314681110","article-title":"Coherent delta-band oscillations between cortical areas correlate with decision making","volume":"110","author":"Nacher","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.neulet.2019.134404_bib0145","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.seizure.2012.10.009","article-title":"Antipsychotics and seizures: Higher risk with atypicals?","volume":"22","author":"Lertxundi","year":"2013","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.neulet.2019.134404_bib0150","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40263-014-0222-y","article-title":"Seizure associated with clozapine: incidence, etiology, and management","volume":"29","author":"Williams","year":"2015","journal-title":"CNS Drugs."},{"issue":"4","key":"10.1016\/j.neulet.2019.134404_bib0155","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/155005940803900410","article-title":"Power spectral frequency and coherence abnormalities in patients with intractable epilepsy and their usefulness in long-term remediation of seizures using neurofeedback","volume":"39","author":"Walker","year":"2008","journal-title":"Clin. EEG Neurosci."},{"issue":"6","key":"10.1016\/j.neulet.2019.134404_bib0160","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1152\/jn.00327.2011","article-title":"Development of hypersynchrony in the cortical network during chemoconvulsant-induced epileptic seizures in vivo","volume":"107","author":"Cymerblit-Sabba","year":"2011","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neulet.2019.134404_bib0165","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/archpsyc.62.12.1297","article-title":"Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia","volume":"62","author":"Reichenberg","year":"2005","journal-title":"Arch. Gen. Psychiatry."},{"key":"10.1016\/j.neulet.2019.134404_bib0170","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1176\/appi.ajp.159.7.1183","article-title":"Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance","volume":"159","author":"Fuller","year":"2002","journal-title":"Am. J. Psychiatry."},{"key":"10.1016\/j.neulet.2019.134404_bib0175","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/0020764006075000","article-title":"Quality of life in schizophrenia on conventional versus a typical antipsychotic medication: a comparative cross-sectional study","volume":"53","author":"Mortimer","year":"2007","journal-title":"Int. J. Soc. Psychiatry."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394019305075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394019305075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:27:10Z","timestamp":1759609630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394019305075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":35,"alternative-id":["S0304394019305075"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2019.134404","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asenapine maleate normalizes low frequency oscillatory deficits in a neurodevelopmental model of schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2019.134404","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"134404"}}